source
- AstraZeneca receives FDA approval for new hypertension medicationAstraZeneca announced that the U.S. Food and Drug Administration has approved its hypertension drug, marking a regulatory milestone for the company. The approval adds to AstraZeneca's cardiovascul…
- Merck and Kelun-Biotech's ADC sac-TMT secures first global Phase 3 win ahead of scheduleMerck and China-based Kelun-Biotech reported that their experimental antibody-drug conjugate sac-TMT achieved a positive outcome in a global Phase 3 study, marking the first such success for the ca…